Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions

13 April 2023 | Thursday | News

Evonik has been honored in the Asia-Pacific Bioprocessing Excellence Awards (ABEA) for its innovative Cell Culture Solutions portfolio. The company won the award for Best New Bioprocessing Supplier in Upstream Processing, in recognition of its high-quality Cell Culture Solutions for pharmaceutical and biotech companies
Image Source : Public Domain

Image Source : Public Domain

  • The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies
  • Evonik recognized for high-quality Cell Culture Solutions
  • Award underscores company’s commitment to driving innovation in the sector

Part of the B2B and marketing intelligence company IMAPAC’s BioPharma Awards, the ceremony, which took place on March 15, celebrates outstanding achievements in the Asian bioprocessing industry. The awards applaud exceptional leaders, organizations and technologies that facilitate innovation and best practice in manufacturing in the region.


“We are honored to have been recognized by the Asia-Pacific biopharma community for our pioneering work to address cell culture media and bioprocessing challenges, to help improve processes and performance,” said Shirley Qi, president Southeast Asia, Australia & New Zealand/head of Nutrition & Care Asia Pacific at Evonik.


Evonik’s extensive Cell Culture Solutions portfolio combines considerable development expertise and manufacturing capabilities to provide highly defined and pure cell culture ingredients for use in a wide range of applications, from biopharmaceutical R&D and manufacturing to medicinal purposes.


“This award underscores our commitment to providing first-class solutions to our customers. We will continue to push the boundaries of biopharmaceutical technology to drive the industry forward,” said Spandan Mishra, associate director business development for biopharma solutions at Evonik Health Care for Asia Pacific.


Evonik’s solutions include the cQrex® portfolio of peptides which address specific amino acid limitations to improve stability and solubility, enabling optimal productivity and enhancing performance in biopharma cell culture media.


Evonik’s Health Care business line is a global innovation hub to the world’s leading pharma and biotech companies. By leveraging six decades of industry leadership, the company provides the biopharma market with high-quality Cell Culture Solutions including amino acids, peptides, plant-based lipids and other non-animal-derived performance boosters.


The ABEA awards ceremony was held in conjunction with the 10th annual Biologics Manufacturing Asia 2023 conference.


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in